CaMKII as a cause of age-related sarcopenia
Sarcopenia, characterized by the progressive loss of skeletal muscle strength, mass, and quality, is a significant risk factor for adverse health outcomes in older adults. The signaling protein, CaMKII, is known for its beneficial role in muscle performance. However, recent findings from Dr. Wang's research indicate that excessive CaMKII activity in aging muscles could inadvertently exacerbate sarcopenia, possibly through augmented chronic inflammation. With the support of AFAR, Dr. Wang aims to elucidate the double-edged role of CaMKII in aging skeletal muscles. This research holds the promise of paving the way for precise therapeutic interventions that can counteract aging-associated muscle deterioration, thereby promoting healthier aging.
